
    
      This is a 10-week, randomized, double-blind, single-site study of treatment with either:
      topiramate, or placebo, or topiramate plus nicotine patch. Approximately, 90 subjects ages
      18-65 who smoke at least 10 cigarettes per day will be screened for study participation, with
      the intention of 60 subjects being eligible for randomized treatment (20 per arm).
    
  